Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise

Recruiting

Phase 2

Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory CompromiseLow Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise

Sponsor:

Ohio State University Comprehensive Cancer Center

Code:

NCT04427566

Conditions

COVID-19

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Radiation therapy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-28. This information was provided to ClinicalTrials.gov by Ohio State University Comprehensive Cancer Center on 2021-03-15.